Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biol Regul Homeost Agents ; 35(2 Suppl. 1): 155-161, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34281312

RESUMO

Tooth extraction produces alveolar bone resorption and soft tissue remodelling, so identification of adequate technique for alveolar ridge preservation after tooth extraction is fundamental for all specific cases. Among the several biomaterials, CGF can represent an ideal alternative considering its and its mechanical and biological properties. In this preliminary study we compared the effectiveness of the use of two different parts of CGF (WP-White Part and BC-Buffy Coat) versus natural healing (CTR) by a split-mouth randomized clinical design. Four healthy patients who needed extraction of three teeth were selected. Post-extractive alveolar sockets were filled randomly with CGF-WP, CGF-BC or nothing for CTR. After 60 days, before implant placement, a biopsy for each alveola was obtained for quantitative histomorphometric analysis. The data obtained showed that the use of CGF-WP could achieve good regenerative results, supporting the use of this part for the preservation of the post-extractive alveolar socket.


Assuntos
Perda do Osso Alveolar , Aumento do Rebordo Alveolar , Perda do Osso Alveolar/etiologia , Perda do Osso Alveolar/prevenção & controle , Processo Alveolar/cirurgia , Transplante Ósseo , Humanos , Boca , Extração Dentária , Alvéolo Dental/cirurgia
2.
Eur Rev Med Pharmacol Sci ; 24(1): 304-314, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31957844

RESUMO

OBJECTIVE: The aim of this study was to test the in vitro differentiation effects of concentrated growth factors (CGF), a platelet rich preparation, using SH-SY5Y cells, derived from human neuroblastoma. MATERIALS AND METHODS: SH-SY5Y cells were cultured in presence of CGF or retinoic acid (RA). After 72 h of treatment, different parameters were investigated: cell proliferation by an automated cell counter; cell viability by thiazolyl blue tetrazolium bromide (MTT) assay; cell differentiation markers, i.e., neuronal nuclear antigen (NeuN), synaptophysin (SYP) and ß3-tubulin, by immunocytochemistry and Western blotting techniques; release of nerve growth factor (NGF) and brain-derived growth factor (BDNF) by enzyme-linked immunosorbent assay (ELISA) and neurite outgrowth by a dedicated image software. RESULTS: In presence of CGF, the cell proliferation rate and viability decreased, as expected for differentiated SH-SY5Y cells. On the contrary, the cellular differentiation markers increased their expression together with the release of growth factors. Moreover, the neurite outgrowth was improved. CONCLUSIONS: The data suggest that CGF treatment positively affects the cell differentiation, regulating the expression of neuronal markers, the release of growth factors and the neurite length. Taken together these results seem to be promising in the development of new approaches for neural regeneration.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/farmacologia , Fator de Crescimento Neural/farmacologia , Neuroblastoma/tratamento farmacológico , Adulto , Fator Neurotrófico Derivado do Encéfalo/análise , Fator Neurotrófico Derivado do Encéfalo/biossíntese , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fator de Crescimento Neural/análise , Fator de Crescimento Neural/biossíntese , Neuroblastoma/metabolismo , Neuroblastoma/patologia
3.
Folia Morphol (Warsz) ; 76(1): 74-81, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27665952

RESUMO

BACKGROUND: Additional extrinsic muscles of the tongue are reported in literature and one of them is the myloglossus muscle (MGM). Since MGM is nowadays considered as anatomical variant, the aim of this study is to clarify some open questions by evaluating and describing the myloglossal anatomy (including both MGM and its ligamentous counterpart) during human cadaver dissections. MATERIALS AND METHODS: Twenty-one regions (including masticator space, sublingual space and adjacent areas) were dissected and the presence and appearance of myloglossus were considered, together with its proximal and distal insertions, vascularisation and innervation. RESULTS: The myloglossus was present in 61.9% of cases with muscular, ligamentous or mixed appearance and either bony or muscular insertion. Facial artery provided myloglossal vascularisation in the 84.62% and lingual artery in the 15.38%; innervation was granted by the trigeminal system (buccal nerve and mylohyoid nerve), sometimes (46.15%) with hypoglossal component. CONCLUSIONS: These data suggest us to not consider myloglossus as a rare anatomical variant.


Assuntos
Língua/anatomia & histologia , Língua/irrigação sanguínea , Língua/inervação , Cadáver , Feminino , Humanos , Masculino
4.
Folia Morphol (Warsz) ; 75(1): 112-116, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26365851

RESUMO

The digastric muscle is an important surgical landmark. Several anatomical variants of the digastric muscle are reported in literature and, in particular, the presence of accessory anterior bellies of the muscle is not uncommon. Here, an unreported symmetrical variant of the digastric muscle was found during a dissection of the suprahyoid region. The dissection showed digastric muscles with an accessory anterior belly, which originated from the anterior belly of muscles in proximity and anteriorly to the intermediate tendon. The accessory bellies were fused together on the midline and were attached with a unique tendon to the inner surface of the mental symphysis. These muscles completely filled the submental triangle. This unreported anatomical variant could be considered an additional contribution to description of the anatomical variants of the digastric muscle, with several implications in head and neck pathology, diagnosis and surgery.


Assuntos
Músculos do Pescoço , Variação Anatômica , Dissecação , Cabeça , Tendões
5.
Int J Immunopathol Pharmacol ; 25(3): 789-91, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23058032

RESUMO

Bevacizumab is a humanized recombinant monoclonal antibody that blocks vascular endothelial growth factor (VEGF). Recently, its use has been related with osteneocrosis of the jaws (ONJ), a disease showing a histological pattern similar to bisphosphonate-related ONJ. The aim of this study is to describe an ONJ case-report following bevacizumab chemotherapy without bisphosphonate therapy. We monitored ONJ development associated with the use of bevacizumab in a 47-year-old male with primitive adenocarcinoma of the parotid gland. Our results could suggest a possible correlation between the eruption of the lower third molar tooth and ONJ development following bevacizumab therapy. Clinicians should be aware of the potential risk of bevacizumab-related ONJ complication; moreover, since there are no effective therapeutic protocols for ONJ treatment, it is very important that patients develop good oral hygiene habits and undergo regular dental status evaluation by dentists.


Assuntos
Adenocarcinoma/tratamento farmacológico , Inibidores da Angiogênese/efeitos adversos , Anticorpos Monoclonais Humanizados/efeitos adversos , Doenças Maxilomandibulares/induzido quimicamente , Osteonecrose/induzido quimicamente , Neoplasias Parotídeas/tratamento farmacológico , Adenocarcinoma/patologia , Bevacizumab , Humanos , Doenças Maxilomandibulares/diagnóstico , Doenças Maxilomandibulares/terapia , Masculino , Pessoa de Meia-Idade , Osteonecrose/diagnóstico , Osteonecrose/terapia , Neoplasias Parotídeas/patologia , Fatores de Tempo , Erupção Dentária/efeitos dos fármacos , Resultado do Tratamento
6.
Histol Histopathol ; 27(8): 1055-66, 2012 08.
Artigo em Inglês | MEDLINE | ID: mdl-22763878

RESUMO

Silicon is not generally considered an essential nutrient for mammals and, to date, whether it has a biological role or beneficial effects in humans is not known. The results of a number of studies suggest that dietary silicon supplementation might have a protective effect both for limiting aluminium absorption across the gut and for the removal of systemic aluminium via the urine, hence, preventing potential accumulation of aluminium in the brain. Since our previous studies demonstrated that aluminium exposure reduces the number of nitrergic neurons, the aim of the present study was to compare the distribution and the morphology of NO-containing neurons in brain cortex of mice exposed to aluminium sulphate dissolved in silicic acid-rich or poor drinking water to assess the potential protective role of silicon against aluminium toxicity in the brain. NADPH-d histochemistry and nNOS immunohistochemistry showed that high concentrations of silicon in drinking water were able to minimize the impairment of the function of nitrergic neurons induced by aluminium administration. We found that silicon protected against aluminium-induced damage to the nitrergic system: in particular, we demonstrated that silicon maintains the number of nitrergic neurons and their expression of nitrergic enzymes at physiological levels, even after a 12 and 15 month exposure to aluminium.


Assuntos
Compostos de Alúmen/toxicidade , Córtex Cerebral/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Neurônios Nitrérgicos/efeitos dos fármacos , Ácido Silícico/farmacologia , Poluentes Químicos da Água/toxicidade , Compostos de Alúmen/análise , Animais , Córtex Cerebral/metabolismo , Córtex Cerebral/patologia , Ingestão de Líquidos , Água Potável/química , Antagonismo de Drogas , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Águas Minerais/análise , NADPH Desidrogenase/metabolismo , Neurônios Nitrérgicos/metabolismo , Neurônios Nitrérgicos/patologia , Óxido Nítrico Sintase Tipo I/metabolismo , Testes de Toxicidade Crônica , Poluentes Químicos da Água/análise
7.
Arch Oral Biol ; 57(4): 323-34, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21996489

RESUMO

Mandibular and maxillary nerve supplies are described in most anatomy textbooks. Nevertheless, several anatomical variations can be found and some of them are clinically relevant. Several studies have described the anatomical variations of the branching pattern of the trigeminal nerve in great detail. The aim of this review is to collect data from the literature and gives a detailed description of the innervation of the mandible and maxilla. We carried out a search of studies published in PubMed up to 2011, including clinical, anatomical and radiological studies. This paper gives an overview of the main anatomical variations of the maxillary and mandibular nerve supplies, describing the anatomical variations that should be considered by the clinicians to understand pathological situations better and to avoid complications associated with anaesthesia and surgical procedures.


Assuntos
Mandíbula/inervação , Maxila/inervação , Nervo Trigêmeo/anatomia & histologia , Anestesia Dentária/métodos , Humanos , Mandíbula/anatomia & histologia , Maxila/anatomia & histologia
8.
Toxicology ; 212(2-3): 155-64, 2005 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-15967562

RESUMO

Cyclosporine A (CsA) is the immunosuppressor, which is most frequently used in transplant surgery and in the treatment of autoimmune diseases. Oxidative stress has been considered as one of the possible mechanisms of CsA-induced cardiotoxicity. The present investigation examines the ability of caffeic acid phenethyl ester (CAPE), which is an active component of propolis extracts, as a natural antioxidant to protect against CsA-induced oxidative stress and cardiotoxicity. CsA cardiotoxicity was induced by subcutaneous injection of CsA at a dose of 15 mg/kg/body weight daily for 21 days in rats. Cardiotoxicity was evaluated by morphological and biochemical studies. CsA treated rats showed degenerative changes with cardiac fibrosis localized around the fibers. These latters were disorganised and the network was disappeared. The ROS production was increased whereas cytochrome-c-oxidase decreased. The expression and levels of matrix metalloproteinase 2 (MMP2) were increased whereas those of its inhibitor were downregulated. CAPE subcutaneous administration (15 micromol/kg/day) improved cardiac cytoarchitecture, decreased the levels and the expression of MMP2, and increased those of TIMP2 proteins. Moreover, it increased cytochrome-c-oxidase activity and decreased ROS production. These results suggest that CAPE could have protective effect against CsA-induced cardiotoxicity.


Assuntos
Ácidos Cafeicos/farmacologia , Ciclosporina , Cardiopatias/prevenção & controle , Imunossupressores , Álcool Feniletílico/análogos & derivados , Substâncias Protetoras/farmacologia , Animais , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Cardiopatias/induzido quimicamente , Cardiopatias/metabolismo , Masculino , Metaloproteinase 2 da Matriz/metabolismo , Miocárdio/enzimologia , Miocárdio/metabolismo , Álcool Feniletílico/farmacologia , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/metabolismo , Inibidor Tecidual de Metaloproteinase-2/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...